Ozon Pharmaceuticals' sales in the first quarter decreased by 4%

Ozon Pharmaceuticals' sales for 3 months of 2026 amounted to 73.3 million packages of medicines, down 4% compared to the previous year. In the public procurement segment, sales increased by 1% to 30 million packages. Retail sales decreased by 8% to 43.3 million packages. The average cost of packaging increased by 7%, to ₽95.6. According to AlphaRM and DSM Group, the retail market volume decreased by 5%-6% in the first quarter of the year.